Becker's Hospital Review | Healthcare News & Analysis

Author's posts

Health system C-suites eye value-based care roles

Healthcare is in flux. Hospitals across the nation report clinician shortages and tight margins, and insurers are pushing more care into the lower cost settings.

Health system C-suites eye value-based care roles

Healthcare is in flux. Hospitals across the nation report clinician shortages and tight margins, and insurers are pushing more care into the lower cost settings.

Biden leans into the ACA

President Joe Biden is highlighting the Affordable Care Act in his 2024 campaign as the law turns 14 and after his Republican opponent signaled loose plans for its demise.    

Biden leans into the ACA

President Joe Biden is highlighting the Affordable Care Act in his 2024 campaign as the law turns 14 and after his Republican opponent signaled loose plans for its demise.    

Tennessee hospitals push back against proposed CON changes

Proposed state legislation to change Tennessee’s certificate-of-need legislation would cause hospital service cuts and closures and reduce care access for many communities across the state, according to the Tennessee Hospital Association. 

21 most innovative health systems, per Fortune

Out of the 200 companies heralded by Fortune as most innovative for 2024, 44 are in healthcare and 21 are health systems. 

4 health systems changing up their C-suites

Several health systems have made multiple changes to their leadership ranks and administration teams in recent months.

Valley Health unveils $800M New Jersey hospital

Ridgewood, N.J.-based Valley Health System held a ribbon cutting March 22 for its new $800 million hospital in Paramus, N.J.

How CFOs' focus has shifted over 3 years

Health systems CFOs are spending more time on cost management and operations and less time on strategy and cash management than they were in 2021, according to a report from the Healthcare Financial Management Association and Eliciting Insights. 

The new COVID-19 drug: 4 notes

More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22.